Being able to communicate in a different language can improve treatment adherence and medication efficacy outcomes
The adjuvant therapy has demonstrated varied efficacy for patients.
Last year in particular, pharmacists played a greater role in patient care with an increased workload as they connected patients, providers, and payers.
Eculizumab (Soliris; Alexion), a C5 inhibitor preventing cleavage into C5a and C5b, is widely considered the first-line therapy for high-risk TA-TMA.
Experts provide practice pearls for educating patients on and using FMTs for the management of CDI.
This movement has aimed to address the mental health care epidemic in the United States.
Health care professionals play a vital role in preventing overdose and ensuring safe use.
Nuances can lead to frequent areas of confusion.
Analyzing consolidation of 8 drug pump libraries into 1 IV infusion library in a 9-hospital system: from standardization to implementation.
BRAF V600E inhibitors show improved outcomes in relapsed/refractory hairy cell leukemia.
A single-center experience at a tertiary medical center precision medicine clinic provides insight.
Gaps in curricula emphasize a need for enhanced interprofessional training to improve patient care.
Pharmacists can help patients with diabetes save money.
Studies show a need for coordination between the VA health care system and non-VA health care practices to decrease confusion and duplication of services.
Point-of-care testing can vary in complexity, but is always performed at or near a patient and at the site where care or treatment is provided.
Self-audits help onsite frontline pharmacy leaders and team members to assess compliance before an external surveyor enters their pharmacy to inspect medication use processes.
A diagnosis of Clostridioides difficile infection does not instantly require treatment, but new guidelines include recommendations for treatment when warranted.
Each therapy presents a different but effective treatment option.
Although the opioid epidemic is a broad societal problem, health systems can play a critical role in the response.
More cost effectiveness data is crucial in advocating for better insurance coverage in the United States.
Panelists discuss how comprehensive educational resources are essential for empowering patients with TD to better understand their condition, actively participate in their treatment decisions, and achieve optimal outcomes through improved self-management and adherence.
This single-center, descriptive, retrospective chart review identified barriers to outpatient chemotherapy use, revealing avoidable inpatient stays and highlighting targets for stewardship interventions.
Members, as well as health plans, pharmacy benefit managers, plan sponsors, and reinsurers want to know how to fund these expensive treatments to ensure positive outcomes.
Some patients incorrectly believe that biosimilars compromise safety or efficacy.
Gianni Scappaticci, PharmD, BCOP, outlines a personalized, evidence-based approach to managing steroid-refractory chronic graft-versus-host disease (cGVHD) in a post–haploidentical transplant patient, highlighting the rationale for using ruxolitinib, belumosudil, or their combination based on disease progression and fibrotic features.
By sharpening our vaccine confidence skills and advocating for expanded immunization scopes of practice, we can help improve convenient vaccine access in the US.
CKD is a complication of diabetes. Emerging treatments aim to optimize management and reduce risks. Pharmacists are key in applying new evidence to clinical practice.
The use of outpatient pharmacy protocols for glucose testing and insulin administration supplies should be expanded to assist patients in the self-management of diabetes.
Katherine H. Saunders, MD, DABOM, explores the role of pharmacists in supporting long-term weight management with GLP-1 therapies, including strategies for counseling on lifestyle interventions, managing adverse effects, and ensuring patients receive individualized, evidence-based care.